Molnupiravir ©
Take the Red Pill ©
Active Ingredients
- Ivermectin 18mg
- Doxycycline 100mg
- Elemental Zinc 300mg
- Vitamin D3 10000iu
Posted on 10/08/2021 9:37:05 PM PDT by bitt
Pharma giant Merck is facing accusations of price gouging after it charged the U.S. more than $700 per patient for a taxpayer-funded coronavirus treatment that, according to research, costs just $17.74 to produce.
he New Jersey-based pharmaceutical giant Merck is facing accusations of price gouging after it charged the U.S. over $700 per patient for a taxpayer-funded coronavirus treatment that, according to research, costs just $17.74 to produce.
Last week, Merck announced plans to request emergency federal authorization for molnupiravir after a late-stage clinical trial showed that a five-day course of the antiviral drug cut the risk of COVID-19 hospitalization or death in half in patients with mild-to-moderate cases.
The same day Merck unveiled the results of the trial and White House officials hailed the drug as another possible tool against COVID-19, the New York Times reported that “the federal government has placed advance orders for 1.7 million courses of treatment, at a price of about $700 per patient” — far more than the estimated cost of manufacturing the drug.
According to an analysis by Melissa Barber of Harvard T. H. Chan School of Public Health and Dzintars Gotham of King’s College Hospital in London, “the cost of production for molnupiravir capsules is U.S. $1.74 per unit, or U.S. $17.74 per five-day regimen.”
“Adding an allowance for 10% profit margin and taxes in India, we arrive at an estimated sustainable generic price of U.S. $1.96 per capsule or U.S. $19.99 per five-day regimen,” the researchers concluded.
Dean Baker, a senior economist at the Center for Economic and Policy Research, noted that the $712 price-per-course price the U.S. government is set to pay for molnupiravir amounts to a roughly 4,000% markup.
Quartz’s Annalisa Merelli reported last week that with Merck expecting to produce 10 million courses of molnupiravir before the end of 2021, the company “could bring in revenue up to $7 billion.”
“This would make it, in only a few weeks, one of the 10 most lucrative drugs ever,” Merelli observed.
...more...
p
also, see
Two Indian drugmakers to end trials of generic Merck pill for moderate COVID-19
Ivermectin coated with red food coloring + Zinc....
But it doesn’t work cries the FDA, CDC, and WHO...right...my *ss! Doing great for me over a year now plus all the other FLCCC prophylactics!
$17 to produce and billions to develop. Not saying I trust Merck since they have been the biggest opponents of Ivermectin. But it is always ignored it takes billions to bribe the regulators and do the research to develop a drug.
they trying to cash in before the gig is up and folks learn that natural immunity is much stronger- and before too many peopel learn that there is a plethora of alternative medicines to help if one should get the virus- and before they learn the truth that 99.97% of the people that get it will be just fine- and that the chance of havign an adverse or fatal reaction to aspirin or tylenol is greater than from covid-
With this behavior by Merck, it tells me the entire country is going to hell in a hand-basket. God will judge them.
From the rave reviews of Molnupiravir, I thought it would be the magic bullet against CIVID-19-Delta. Now it looks like a pipe dream with a pipe full of pot.
4,000 %?? Price gouging on a massive scale, and no Consumer Affairs who will do a damn thing about it.
I don’t know if this specific markup is too high but drug companies spend and lose many millions trying to develop drugs, most of which never get to market for various reasons and are total losses for the companies.
I’m not a fan of these shots this is just the way that business works. If they didn’t blow millions on failures, they’d never get the successful drugs. And there are way more failures than successes.
Fortunes are being made on this plandemic. And that, folks, is why they rush to discourage and discredit the use of any treatment that is cheap: Ivermectin, hydroxychloroquine, z-pac, zinc, vitamin D, etc
I’m not certain what the numbers are today, but 65% of the cost of bringing a drug to market was paid for by US taxpayers. I doubt that has changed.
BigPharma, BigInsurance, BigHospitals — the unholy trinity of extortion.
What?
Business as usual suddenly nis a problem?
We consumers have been getting shafted like that by big pharma for decades and NOW someone finally objects????
Merck recently was on a disinformation campaign, suddenly trying to discredit its original but now off-patent Ivermectin drug, which is long-proven safe, is very inexpensive, and has been demonstrated to be very effective for this new use.
Meanwhile it doesn’t sound like these new “treatments” are good news after all, starting at the 26:45 mark here: https://www.redvoicemedia.com/2021/10/stew-peters-show-fighting-for-parents-saving-our-schools-the-battle-against-communist-tyrants/
Notice the ONLY time these far Leftists clowns get in an uproar is when anything appears that challenges the Jab?
They spend more on advertising than on research.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.